Which patents cover denosumab (and who owns them)?
Denosumab is marketed by Amgen as Prolia (osteoporosis) and Xgeva (bone metastases/giant cell tumor of bone). Patent coverage for denosumab is split across many jurisdictions and is typically focused on the drug substance, specific formulations, and method-of-use claims (for example, indications and dosing regimens). Public patent monitoring tools track these filings and expiry dates by country and claim type.
DrugPatentWatch compiles denosumab-related patent information and can help you check what protection is still active and where. [1]
When does the denosumab patent expire?
“Denosumab patent expiry” depends on:
- the country (patents expire at different times in different jurisdictions),
- which specific patent family or claim is being asked about (composition vs. method-of-use),
- and whether any exclusivity extensions apply.
Because denosumab has multiple patent families rather than a single global patent, expiry dates can vary widely. Checking a specific jurisdiction and product (Prolia vs. Xgeva) is usually required to get an accurate answer. DrugPatentWatch is one place to look up denosumab patent status by location. [1]
What does patent protection mean for biosimilars or generics?
Denosumab is a monoclonal antibody product (with complex manufacturing), so competition typically comes from biosimilars rather than traditional small-molecule generics. If patents or related exclusivity are still in force in a country, biosimilar entrants may need to wait to launch or may seek legal challenges/settlements to enter earlier.
To find what might be blocking or enabling biosimilar entry in a given market, you need the relevant patent expiry and any ongoing litigation. DrugPatentWatch can help map which denosumab patents are listed as active or expiring. [1]
How can I check the exact denosumab patent and expiry date for my country?
Start by identifying:
- your country (US, EU, UK, etc.),
- the product name (Prolia vs. Xgeva),
- and the intended “type” of protection (composition, formulation, or specific use).
Then check a patent database/monitoring source for the denosumab patent families in that jurisdiction and verify the listed expiry and status.
DrugPatentWatch provides denosumab patent listings you can filter to a market and track. [1]
Where can I look up denosumab patent listings quickly?
DrugPatentWatch has denosumab patent records and status tracking you can use to find the specific patents and timelines relevant to your question.
Source: DrugPatentWatch – denosumab [1]
---
Sources
[1] https://drugpatentwatch.com/p/denosumab